FDA Grants Orphan Drug Designation to Ganaxolone for Lennox-Gastaut Syndrome
https://pixabay.com/en/epilepsy-seizure-stroke-headache-623346/

FDA Grants Orphan Drug Designation to Ganaxolone for Lennox-Gastaut Syndrome

  Prior to the end of March 2023, ganaxolone had received six separate Orphan Drug designations from the FDA; more recently, as shared in a news release from commercial-stage pharmaceutical…

Continue Reading FDA Grants Orphan Drug Designation to Ganaxolone for Lennox-Gastaut Syndrome